- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Yuhan (000100)
The Yuhan share price today is 69,600, view KS 000100 stock exchange data. Track the latest Yuhan share price with real-time updates on 000100 stock performance including market cap, day range, 52-week range and dividend yield. Access 000100 charts, earnings dates and analyst estimates to support your investment decisions.
69,600
-800(-1.14%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
68,300
71,100
52 wk Range
65,000
136,400
000100 is included in our AI-picked strategies. See how they work
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
68,30071,100
52 wk Range
65,000136,400
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.86%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.86%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
000100 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
129,222
Upside
+85.66%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Prominent player in the Pharmaceuticals industry
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
Analyst Ratings
14 Buy
2 Hold
2 Sell
Ratings:
18 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 129,222
(+85.66% Upside)
Earnings
Latest Release
15-05-2026
EPS / Forecast
289.13 / 521.27
Revenue / Forecast
526.9B / 543.9B
Compare 000100 to Peers and Sector
Metrics to compare | 000100 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship000100PeersSector | |
|---|---|---|---|---|
P/E Ratio | 25.1x | 8.6x | −0.4x | |
PEG Ratio | 0.12 | 0.08 | 0.00 | |
Price/Book | 2.3x | 0.9x | 2.6x | |
Price / LTM Sales | 2.4x | 0.7x | 3.0x | |
Upside (Analyst Target) | 92.6% | 55.0% | 49.1% | |
Fair Value Upside | Unlock | 15.0% | 6.3% | Unlock |
Yuhan Corporation operates as a pharmaceutical company in South Korea and internationally. It offers manufacturing services, such as custom manufacturing; process research and development of active pharmaceutical products (APIs) and intermediates; kilo and pilot-scale production of APIs and intermediates; commercial production of APIs and intermediates; production of chemical specialties; and analytical method development and regulatory support. The company also provides APIs and intermediates, including antibiotic, anti-thrombotic, anti-hyperlipidemics, and anti-hypertensive; and custom synthesis services through commercial supply in areas of anti-viral, anti-HIV, anti-HCV, anti-biotic, antihistamine, anti-diabetic, ß-lactamase inhibitor, CNS intermediate, PEG-compounds, and others. Yuhan Corporation was founded in 1926 and is headquartered in Seoul, South Korea.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Yuhan (000100) Share Price Today?
The Yuhan share price today is 69,600.
What is the current Yuhan (000100) share price and day range?
As of 06-07-2026, the Yuhan share price is 69,600, with a previous close of 70,400. The share price has ranged from 68,300 to 71,100 today, while the 52-week range spans from 65,000 to 1,36,400.
What Is the Yuhan Market Cap?
As of today, Yuhan market cap is 5.25T.
Does Yuhan Pay Dividends? What's The Current Dividend Yield?
The Yuhan dividend yield is 0.86%.
What Is the Yuhan (000100) Share Price Target?
The average 12-month share price target for Yuhan is 1,29,222, with a high estimate of 170000 and a low estimate of 81000. 14 analysts recommend buying, while 2 suggest selling, with an overall rating of Buy and +85.66% Upside potential.
What Is Yuhan's Earnings Per Share (TTM)?
The Yuhan EPS (TTM) is 2,804.
When Is the Next Yuhan Earnings Date?
Yuhan will release its next earnings report on 18-08-2026.
From a Technical Analysis Perspective, Is 000100 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does Yuhan Trade On?
Yuhan is listed and trades on the Seoul Stock Exchange.
What Is the Stock Symbol for Yuhan?
The stock symbol for Yuhan is "000100."
How Many Times Has Yuhan Stock Split?
Yuhan has split 25 times.
How Many Employees Does Yuhan Have?
Yuhan has 2087 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.